Proteasomal degradation of RBM39 for neuroblastoma

Inhibiting the RNA splicing factor RBM39 could help treat neuroblastoma. Bioinformatic analysis of drug sensitivity in 758 cell lines identified neuroblastoma as the tumor type most sensitive to indis...